Cover Image

Considerations for evaluating the effectiveness and long-term outcome of enzyme replacement therapy in Pompe disease

Saved in:

Bibliographic Details
Main Author:	Chong Kun Cheon (Author)
Format:	Book
Published:	The Korean Pediatric Society, 2020-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cognitive Outcome of Infants with Pompe Disease Receiving Enzyme-Replacement Therapy
by: J Gordon Millichap
Published: (2012)

Improved Enzyme Replacement Therapy with Cipaglucosidase Alfa/Miglustat in Infantile Pompe Disease
by: Lina Fiege, et al.
Published: (2023)

Effect of the enzyme replacement therapy on hypertrophic cardiomyopathy in an infant with the CRIM-negative infantile Pompe's disease
by: Guy Vaksmann, et al.
Published: (2021)

Enzyme Replacement Therapy (ERT) on Heart Function Changes the Outcome in Patients with Infantile-Onset Pompe Disease: A Familial History
by: Marco Lecis, et al.
Published: (2023)

Fabry nephropathy before and after enzyme replacement therapy: important role of renal biopsy in patients with Fabry disease
by: Il Young Kim, et al.
Published: (2021)

Exercise, nutrition and enzyme replacement therapy are efficacious in adult Pompe patients: report from EPOC Consortium
by: Corrado Angelini
Published: (2021)

Efficacy and safety of enzyme replacement therapy with alglucosidase alfa for the treatment of patients with infantile-onset Pompe disease: a systematic review and metanalysis
by: A. D. Dornelles, et al.
Published: (2024)

Alglucosidase alfa: Long term use in the treatment of patients with Pompe disease
by: Michael Beck
Published: (2009)

Clinical and molecular characterization of Korean children with infantile and late-onset Pompe disease: 10 years of experience with enzyme replacement therapy at a single center
by: Min-Sun Kim, et al.
Published: (2019)

Case report of unexpected gastrointestinal involvement in type 1 Gaucher disease: comparison of eliglustat tartrate treatment and enzyme replacement therapy
by: Yoo-Mi Kim, et al.
Published: (2017)

Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10- Year Fabry Outcome Survey (FOS) Analysis
by: Ramaswami U, et al.
Published: (2019)

EVALUATION OF ENZYME REPLACEMENT THERAPY EFFECTIVENESS IN CHILDREN WITH GAUCHER'S DISEASE ACCORDING TO THE INTERNATIONAL STUDIES
by: O. S. Gundobina, et al.
Published: (2014)

Comparing the efficacy of cipaglucosidase alfa plus miglustat with other enzyme replacement therapies for late-onset Pompe disease: a network meta-analysis utilizing patient-level and aggregate data
by: Simon Shohet, et al.
Published: (2024)

Esophageal replacement in children: Challenges and long-term outcomes
by: Giampiero Soccorso, et al.
Published: (2016)

Case Report: Anesthetic Management and Electrical Cardiometry as Intensive Hemodynamic Monitoring During Cheiloplasty in an Infant With Enzyme-Replaced Pompe Disease and Preserved Preoperative Cardiac Function
by: Meng-Chen Liu, et al.
Published: (2021)

Statistical considerations in long-term efficacy evaluation of anti-cancer therapies
by: Ruobing Li, et al.
Published: (2023)

Enzyme replacement therapy: efficacy and limitations
by: Daniela Concolino, et al.
Published: (2018)

An open-label clinical trial of agalsidase alfa enzyme replacement therapy in children with Fabry disease who are naïve to enzyme replacement therapy
by: Goker-Alpan O, et al.
Published: (2016)

Infantile-onset Pompe disease complicated by sickle cell anemia: Case report and management considerations
by: Rodrigo Tzovenos Starosta, et al.
Published: (2022)

Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease
by: V. I. Ignatyeva, et al.
Published: (2019)

Enzyme replacement therapy for Fabry disease: some answers but more questions
by: Majid Alfadhel, et al.
Published: (2011)

Changing Times for CLN2 Disease: The Era of Enzyme Replacement Therapy
by: Specchio N, et al.
Published: (2020)

Clinical features and enzyme replacement therapy in 10 children with Fabry disease
by: Qian Li, et al.
Published: (2023)

Disease Progression Modeling to Evaluate the Effects of Enzyme Replacement Therapy on Kidney Function in Adult Patients with the Classic Phenotype of Fabry Disease
by: Albina Nowak, et al.
Published: (2017)

Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism
by: Maurício de Almeida Ferreira, et al.
Published: (2022)

Dental effects of enzyme replacement therapy in case of childhood-type hypophosphatasia
by: Rena Okawa, et al.
Published: (2021)

Newborn Screening for Pompe Disease
Published: (2021)

CARDIOVASCULAR INVOLVEMENT IN POMPE DISEASE
by: Alina-Costina Luca, et al.
Published: (2017)

Newborn Screening for Pompe Disease
by: Takaaki Sawada, et al.
Published: (2020)

Mucopolysaccharidosis type II: Enzyme Replacement Therapy Efficiency
by: Nato D. Vashakmadze, et al.
Published: (2020)

PECULIARITIES OF REPLACEMENT ENZYME THERAPY IN CHILDREN WITH CYSTIC FIBROSIS: BENEFITS OF HIGH-TECH ENZYMES
by: O.I. Simonova, et al.
Published: (2011)

PECULIARITIES OF REPLACEMENT ENZYME THERAPY IN CHILDREN WITH CYSTIC FIBROSIS: BENEFITS OF HIGH-TECH ENZYMES
by: O.I. Simonova, et al.
Published: (2011)

Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease
by: Goláň L, et al.
Published: (2015)

Results of 14-year-long Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II: Clinical Case
by: Natalia V. Zhurkova, et al.
Published: (2023)

ALGLUCOSIDASE ALFA - A NEW STAGE IN THE THERAPY OF INFANTILE POMPE DISEASE
by: E. N. Basargina, et al.
Published: (2014)

Cardiovascular findings and effects of enzyme replacement therapy in patients with mucopolysaccharidosis type VI
by: Emine Azak, et al.
Published: (2019)

Association of hypoalbuminemia with short-term and long-term mortality in patients undergoing continuous renal replacement therapy
by: Jong Joo Moon, et al.
Published: (2020)

Lysosomal acid lipase deficiency: analysis of enzyme replacement therapy
by: N.A. Polyanskaya, et al.
Published: (2022)

Development of Newborn Screening for Pompe Disease
by: Wuh-Liang Hwu, et al.
Published: (2020)

The Pomp of Yesterday
by: Hocking, Joseph, 1860-1937